MLGCN-Driver enhances cancer driver gene identification using multi-layer GCN and topological features, suggesting improved accuracy.
The progression of cancer is driven by the accumulation of mutations in driver genes. Many researches promote to identify cancer driver genes. However, most of them ignore the high-order features in the network. In this study, we propose a novel method MLGCN-Driver based on multi-layer graph convolutional neural networks (GCN) to boost driver gene identification. MLGCN-Driver employs multi-layer GCN with initial residual connections and identity mappings to learn biological multi-omics features within biological networks. In addition, node2vec algorithm is used to extract the topological structure features of the biological network, and then the features are fed into another multi-layer GCN for feature learning. Meanwhile, the initial residual connections and identity mappings mitigate the over-smooth of features. Finally, the probability of each gene being a driver gene is calculated based on low-dimensional biological features and topological features. We applied the MLGCN-Driver on pan-cancer dataset and cancer type-specific datasets. Experimental results demonstrate the excellent performance of MLGCN-Driver in terms of the area under the ROC curve (AUC) and the area under the precision-recall curve (AUPRC) when compared with state-of-the-art approaches.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: